Domain-specific patterns of physical activity and risk of breast cancer sub-types in the MCC-Spain study.


Journal

Breast cancer research and treatment
ISSN: 1573-7217
Titre abrégé: Breast Cancer Res Treat
Pays: Netherlands
ID NLM: 8111104

Informations de publication

Date de publication:
Oct 2019
Historique:
received: 26 04 2019
accepted: 12 07 2019
pubmed: 19 7 2019
medline: 12 2 2020
entrez: 19 7 2019
Statut: ppublish

Résumé

Literature on the separate effects of physical activities (PA) on risk of breast cancer (BC) sub-types is heterogeneous. We investigated domain-specific associations between PA and BC risk by menopausal status and molecular subtype. 1389 histologically confirmed invasive BC cases and 1712 controls from the MCC-Spain study were included (age: 20-85 years). Questionnaire information on PA at work, at home, and during leisure time, including recreational PA and sedentary time, and data on reproductive history, anthropometry, family history of BC, diet, and lifestyles were obtained through face-to-face interviews. Information on the expression of oestrogen (ER), progesterone (PR), and HER2 receptors was available for > 95% of the cases. Mixed-effects multivariable logistic regression models were used to estimate odds ratios (OR) of BC sub-types. Occupational PA (OPA) intensity was associated with higher BC risk. Associations were stronger for pre-menopausal (OR Higher levels of HPA and RPA were associated with lower risk of BC, with heterogeneity by molecular type, whereas sitting time was a consistent independent risk factor of BC risk. The positive association found for OPA with ER+/PR+ BC deserves further investigation.

Identifiants

pubmed: 31317349
doi: 10.1007/s10549-019-05358-x
pii: 10.1007/s10549-019-05358-x
doi:

Substances chimiques

Biomarkers, Tumor 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

749-760

Subventions

Organisme : Spanish Ministry Council, Acción Transversal del Cáncer
ID : 2007
Organisme : Instituto de Salud Carlos III-FEDER
ID : PI08/1770
Organisme : Instituto de Salud Carlos III-FEDER
ID : PI08/0533
Organisme : Instituto de Salud Carlos III-FEDER
ID : PI08/1359
Organisme : Instituto de Salud Carlos III-FEDER
ID : PS09/00773
Organisme : Instituto de Salud Carlos III-FEDER
ID : PS09/01286
Organisme : Instituto de Salud Carlos III-FEDER
ID : PS09/01903
Organisme : Instituto de Salud Carlos III-FEDER
ID : PS09/02078
Organisme : Instituto de Salud Carlos III-FEDER
ID : PS09/01662
Organisme : Instituto de Salud Carlos III-FEDER
ID : PI11/01403
Organisme : Instituto de Salud Carlos III-FEDER
ID : PI11/01889-FEDER
Organisme : Instituto de Salud Carlos III-FEDER
ID : PI11/00226
Organisme : Instituto de Salud Carlos III-FEDER
ID : PI11/01810
Organisme : Instituto de Salud Carlos III-FEDER
ID : PI11/02213
Organisme : Instituto de Salud Carlos III-FEDER
ID : PI12/00488
Organisme : Instituto de Salud Carlos III-FEDER
ID : PI12/00265
Organisme : Instituto de Salud Carlos III-FEDER
ID : PI12/00715
Organisme : Instituto de Salud Carlos III-FEDER
ID : PI12/00150
Organisme : Instituto de Salud Carlos III-FEDER
ID : PI14/01219
Organisme : Instituto de Salud Carlos III-FEDER
ID : PI14/0613
Organisme : Instituto de Salud Carlos III-FEDER
ID : PI15/00069
Organisme : Instituto de Salud Carlos III-FEDER
ID : PI15/00069
Organisme : Instituto de Salud Carlos III-FEDER
ID : PI15/00914
Organisme : Instituto de Salud Carlos III-FEDER
ID : PI15/01032
Organisme : Instituto de Salud Carlos III-FEDER
ID : PI17CIII/00034
Organisme : Fundación Marqués de Valdecilla
ID : API 10/09
Organisme : MINECO: ISCIII-RTICC
ID : RD12/0036/0036
Organisme : Junta de Castilla y León
ID : LE22A10-2
Organisme : Consejería de Salud de la Junta de Andalucía
ID : PI-0571-2009
Organisme : Consejería de Salud de la Junta de Andalucía
ID : PI-0306-2011
Organisme : Consejería de Salud de la Junta de Andalucía
ID : salud201200057018tra
Organisme : Conselleria de Sanitat of the Generalitat Valenciana
ID : AP_061/10
Organisme : Recercaixa
ID : 2010ACUP 00310
Organisme : European Commission
ID : Grants FOOD-CT-2006-036224-HIWATE
Organisme : Catalan Government-Agency for Management of University and Research Grants (AGAUR)
ID : Grants 2017SGR723 and 2014SGR850

Auteurs

José M Huerta (JM)

Department of Epidemiology, Murcia Regional Health Council, IMIB-Arrixaca, Ronda de Levante 11, 30008, Murcia, Spain.
CIBER Epidemiología Y Salud Pública (CIBERESP), Av. Monforte de Lemos, 3-5, 28029, Madrid, Spain.

Antonio J Molina (AJ)

Grupo de Investigación en Interacciones Gen-Ambiente Y Salud (GIIGAS), Instituto de Biomedicina (IBIOMED), Universidad de León, Campus de Vegazana, s/n, 24071, León, Spain. ajmolt@unileon.es.
Área de Medicina Preventiva y Salud Pública. Departamento de Ciencias Biomédicas, Universidad de León, Campus de Vegazana, s/n, 24071, León, Spain. ajmolt@unileon.es.

María Dolores Chirlaque (MD)

Department of Epidemiology, Murcia Regional Health Council, IMIB-Arrixaca, Ronda de Levante 11, 30008, Murcia, Spain.
CIBER Epidemiología Y Salud Pública (CIBERESP), Av. Monforte de Lemos, 3-5, 28029, Madrid, Spain.
Departamento de Ciencias Sociosanitarias, Facultad de Medicina, Universidad de Murcia, Campus de Espinardo, 30100, Murcia, Spain.

Pedro Yepes (P)

Department of Epidemiology, Murcia Regional Health Council, IMIB-Arrixaca, Ronda de Levante 11, 30008, Murcia, Spain.

Ferrán Moratalla-Navarro (F)

CIBER Epidemiología Y Salud Pública (CIBERESP), Av. Monforte de Lemos, 3-5, 28029, Madrid, Spain.
Oncology Data Analytics Program (ODAP), Catalan Institute of Oncology and Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL), Gran Via de L'Hospitalet, 199, 08908, Hospitalet de Llobregat, Spain.

Víctor Moreno (V)

CIBER Epidemiología Y Salud Pública (CIBERESP), Av. Monforte de Lemos, 3-5, 28029, Madrid, Spain.
Oncology Data Analytics Program (ODAP), Catalan Institute of Oncology and Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL), Gran Via de L'Hospitalet, 199, 08908, Hospitalet de Llobregat, Spain.
Department of Clinical Sciences, Faculty of Medicine, University of Barcelona, Feixa Llarga, s/n, 08907, Hospitalet de Llobregat, Spain.

Pilar Amiano (P)

CIBER Epidemiología Y Salud Pública (CIBERESP), Av. Monforte de Lemos, 3-5, 28029, Madrid, Spain.
Public Health Division of Gipuzkoa, Biodonostia Research Institute, Avda. de Navarra, 4, 20013, Donostia-San Sebastián, Spain.

Marcela Guevara (M)

CIBER Epidemiología Y Salud Pública (CIBERESP), Av. Monforte de Lemos, 3-5, 28029, Madrid, Spain.
Navarra Public Health Institute, Calle Leyre, 15, 31003, Pamplona, Spain.
IdiSNA, Navarra Institute for Health Research, C/ Irunlarrea, 3, 31008, Pamplona, Spain.

Conchi Moreno-Iribas (C)

Navarra Public Health Institute, Calle Leyre, 15, 31003, Pamplona, Spain.
IdiSNA, Navarra Institute for Health Research, C/ Irunlarrea, 3, 31008, Pamplona, Spain.
REDISSEC, Red de Investigación en Servicios de Salud en Enfermedades Crónicas, Madrid, Spain.

Javier Llorca (J)

CIBER Epidemiología Y Salud Pública (CIBERESP), Av. Monforte de Lemos, 3-5, 28029, Madrid, Spain.
Facultad de Medicina, Universidad de Cantabria, Av. Cardenal Herrera Oria, s/n, 39011, Santander, Spain.

Guillermo Fernández-Tardón (G)

CIBER Epidemiología Y Salud Pública (CIBERESP), Av. Monforte de Lemos, 3-5, 28029, Madrid, Spain.
Instituto Universitario de Oncología, Universidad de Oviedo, C/ Julián Clavería, s/n, 33006, Oviedo, Spain.
Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Av. Roma, s/n, 33011, Oviedo, Spain.

Ana Molina-Barceló (A)

Cancer and Public Health Area, FISABIO-Public Health, Avda. de Catalunya, 21, 46020, Valencia, Spain.

Juan Alguacil (J)

CIBER Epidemiología Y Salud Pública (CIBERESP), Av. Monforte de Lemos, 3-5, 28029, Madrid, Spain.
Centro de Investigación en Recursos Naturales, Salud Y Medio Ambiente (RENSMA), Universidad de Huelva, Avda. de Las Fuerzas Armadas, s/n, 21007, Huelva, Spain.

Rafael Marcos-Gragera (R)

CIBER Epidemiología Y Salud Pública (CIBERESP), Av. Monforte de Lemos, 3-5, 28029, Madrid, Spain.
Epidemiology Unit and Girona Cancer Registry. Oncology Coordination Plan, Department of Health, Autonomous Government of Catalonia, Catalan Institute of Oncology, Av. França, s/n, 17007, Girona, Spain.
Descriptive Epidemiology, Genetics and Cancer Prevention Group, Biomedical Research Institute (IDIBGI), C/ Dr. Castany, s/n, 17190, Salt, Spain.

Gemma Castaño-Vinyals (G)

CIBER Epidemiología Y Salud Pública (CIBERESP), Av. Monforte de Lemos, 3-5, 28029, Madrid, Spain.
ISGlobal, C/ Rosselló, 132, 08036, Barcelona, Spain.
IMIM (Hospital del Mar Medical Research Institute), C/ Doctor Aiguader, 88, 08003, Barcelona, Spain.
Universitat Pompeu Fabra (UPF), Plaza de La Merced, 10, 08002, Barcelona, Spain.

Beatriz Pérez-Gómez (B)

CIBER Epidemiología Y Salud Pública (CIBERESP), Av. Monforte de Lemos, 3-5, 28029, Madrid, Spain.
Environmental and Cancer Epidemiology Department, National Centre of Epidemiology-Instituto de Salud Carlos III, C/ Melchor Fernández Almagro, 5, 28029, Madrid, Spain.
Oncology and Hematology Area, IIS Puerta De Hierro, Cancer Epidemiology Research Group, C/ Manuel de Falla, 1, 28222, Majadahonda, Madrid, Spain.

Manolis Kogevinas (M)

CIBER Epidemiología Y Salud Pública (CIBERESP), Av. Monforte de Lemos, 3-5, 28029, Madrid, Spain.
ISGlobal, C/ Rosselló, 132, 08036, Barcelona, Spain.
IMIM (Hospital del Mar Medical Research Institute), C/ Doctor Aiguader, 88, 08003, Barcelona, Spain.
Universitat Pompeu Fabra (UPF), Plaza de La Merced, 10, 08002, Barcelona, Spain.

Marina Pollán (M)

CIBER Epidemiología Y Salud Pública (CIBERESP), Av. Monforte de Lemos, 3-5, 28029, Madrid, Spain.
Environmental and Cancer Epidemiology Department, National Centre of Epidemiology-Instituto de Salud Carlos III, C/ Melchor Fernández Almagro, 5, 28029, Madrid, Spain.
Oncology and Hematology Area, IIS Puerta De Hierro, Cancer Epidemiology Research Group, C/ Manuel de Falla, 1, 28222, Majadahonda, Madrid, Spain.

Vicente Martín (V)

CIBER Epidemiología Y Salud Pública (CIBERESP), Av. Monforte de Lemos, 3-5, 28029, Madrid, Spain.
Grupo de Investigación en Interacciones Gen-Ambiente Y Salud (GIIGAS), Instituto de Biomedicina (IBIOMED), Universidad de León, Campus de Vegazana, s/n, 24071, León, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH